Aldámiz-Echevarría L, Couce ML, Llarena M, Andrade F (2014). A new case of maternal phenylketonuria treated with sapropterindihydrochloride (6R-BH4). Gynecol Endocrinol 30: 691–3.
Andersson HC (2013). 50 Years ago in The Journal of Pediatrics: Children of mothers with phenylketonuria. Pediatrics163:671.
Aubard Y, Darodes N, Cantaloube M (2000). Hyperhomocysteinemia and pregnancy—review of our present understanding and therapeutic implications. Eur J Obstet Gyncol Reprod Biol2000;93:157–65.
Blau N, FJ van Spronsen, Levy HL (2010). Phenylketonuria. The Lancet 376: 1417–27.
Chen RG, Chen HY, Shi SZ, Bai NQ, Ding XJ, Ding Y, et al (1983).Preliminary report on neonatal screening for hypothyroidism, phenylketonuria and galactosemia. Shanghai Medical Journal 6:344–6.
Conoley JC, Impera JC (1995) Gesell Child Developmental Age Scale. The Twelfth Mental Measurements Yearbook.
Feillet F, Ficicioglu C, Lagler FB, et al (2017).An Interim Analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) and Phenylketonuria Developmental Outcomes and Safety (PKU MOMs) Registries: Pregnancies.Presented at the 13th International Congress of Inborn Errors of Metabolism: September 5–8, 2017, Rio de Janeiro, Brazil.
Guthrie R, Susi A (1963). A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics32: 338–43.
Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B, et al (2003). The maternal phenylketonuria international study: 1984–2002. Pediatrics 112: 1523–99.
Langendonk JG, Roos JC, Angus L, Williams M, Karstens FP, de Klerk JB,et al (2012).A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis 35:419–24.
Lenke RR, Levy HL (1980). Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies. N Engl J Med 1980;303:1202–8.
Levy HL. Historical background for the maternal PKU syndrome (2003).Pediatrics 112:1516–8.
Liu YP, Wang Q, Li XY, Ding Y, Song JQ, Yang YL (2015). First Chinese case of successful pregnancy with combined methylmalonicaciduria and homocystinuria, cblC type. Brain & Development 37:286–91.
Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008). Factors influencing outcomes in the off spring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88: 700–5.
Mei L, Song P, Xu L (2013). Newborn screening and related policy against Phenylketonuria in China. Intractable Rare Dis Res 2:72–6.
Moseley K, Skrabal J, Yano S,Koch R (2009). Sapropterindihydrochloride (6R-BH4) and maternal phenylketonuria: two case studies[J]. Infant Child Adolesc Nutr 1: 262–6.
Platt LD, Koch R, Hanley WB, Lew HL, Matalon R, Rouse B, et al (2000). The International Study of Pregnancy Outcome in Women with Maternal Phenylketonuria: Report of a 12 year Study. Am J Obstet Gynecol 182:326–33.
Shen M (2016). Paying more attention to the prevention and treatment of maternal phenylketonuria. Chin J Appl Clin Pediatr31(20):1521–1524.
Shi XT, Cai J, Wang YY, Tu WJ, Wang WP, Gong LM, et al (2012). Newborn screening for inborn errors of metabolism in mainland chinaChina: 30 years of experience. JIMD Rep 6:79–83.
Wang L, Zou H, Ye F, Wang KD, Li XW, Chen ZH, et al (2017).Household financial burden of phenylketonuria treatment in China: a cross-sectional study. J Inherit Metab Dis 40:369–76.
Widaman KF, Azen C (2003). Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the international maternal PKU collaborative study. Pediatrics 112: 1537–43.